Hypothyroid dogs treated with intravenous levothyroxine

Area of Science:

• Veterinary Medicine
• Endocrinology
• Internal Medicine

Background:

• Hypothyroidism in dogs can present with nonspecific clinical and clinicopathologic findings.
• A hypothyroid crisis, a severe form of hypothyroidism, requires prompt recognition and treatment.
• Rottweiler dogs may have an increased predisposition to severe hypothyroidism.

Purpose of the Study:

• To evaluate clinical and clinicopathologic findings in hypothyroid dogs treated with intravenous levothyroxine (IV).
• To assess treatment response and outcomes in dogs receiving IV levothyroxine.
• To identify risk factors and characteristic signs associated with hypothyroid crisis.

Main Methods:

• Retrospective study including 7 dogs treated with IV levothyroxine and 799 other hypothyroid dogs.
• Analysis of clinical signs, clinicopathologic data, and treatment responses.
• Comparison of signalment and clinical presentation between IV levothyroxine-treated dogs and the general hypothyroid population.

Main Results:

• Rottweiler dogs were significantly overrepresented in the IV levothyroxine treatment group.
• Common abnormalities included obesity, mental dullness, nonpitting edema, anemia, and hypercholesterolemia.
• Six of seven dogs showed subjective improvement in mentation or ambulation within 30 hours of IV levothyroxine administration, with a good overall treatment response.

Conclusions:

• Clinical and clinicopathologic findings in hypothyroid crisis are nonspecific, but Rottweilers may be at higher risk.
• Concurrent diseases, medications, or surgery may contribute to the development of hypothyroid crisis.
• Intravenous levothyroxine administration is effective, with expected rapid improvement in mentation, ambulation, and resolution of systolic hypotension, leading to a generally good prognosis.